spacer
spacer

PDBsum entry 1koe

Go to PDB code: 
Top Page protein links
Angiogenesis inhibitor PDB id
1koe
Contents
Protein chain
172 a.a.
Waters ×83

References listed in PDB file
Key reference
Title Crystal structure of the angiogenesis inhibitor endostatin at 1.5 a resolution.
Authors E.Hohenester, T.Sasaki, B.R.Olsen, R.Timpl.
Ref. EMBO J, 1998, 17, 1656-1664. [DOI no: 10.1093/emboj/17.6.1656]
PubMed id 9501087
Abstract
A number of extracellular proteins contain cryptic inhibitors of angiogenesis. Endostatin is a 20 kDa C-terminal proteolytic fragment of collagen XVIII that potently inhibits endothelial cell proliferation and angiogenesis. Therapy of experimental cancer with endostatin leads to tumour dormancy and does not induce resistance. We have expressed recombinant mouse endostatin and determined its crystal structure at 1.5 A resolution. The structure reveals a compact fold distantly related to the C-type lectin carbohydrate recognition domain and the hyaluronan-binding Link module. The high affinity of endostatin for heparin is explained by the presence of an extensive basic patch formed by 11 arginine residues. Endostatin may inhibit angiogenesis by binding to the heparan sulphate proteoglycans involved in growth factor signalling.
Figure 2.
Figure 2 Stereo view of the final 2F[obs]-F[calc] map at 1.5 Å resolution. The region around -strand P is shown, with the disulphide bond between Cys164 and Cys304 in the centre. The map is contoured at the 1.5 level and is shown with the refined model superimposed. The figure was made with BOBSCRIPT (R.Esnouf, personal communication), a modified version of MOLSCRIPT (Kraulis, 1991).
Figure 5.
Figure 5 Electrostatic surface representation (Nicholls, 1992) of endostatin. The two views of the endostatin surface are related by a rotation of 130° about the horizontal axis. Blue indicates regions of positive potential and red regions of negative potential, at the 5 kT/e level. The N- and the C-termini are indicated; basic residues and the solvent-exposed side chains of Phe162 and Phe165 are labelled in yellow and white, respectively. The hatched area corresponds to the oligosaccharide-binding site of C-type lectin CRDs.
The above figures are reprinted from an Open Access publication published by Macmillan Publishers Ltd: EMBO J (1998, 17, 1656-1664) copyright 1998.
Secondary reference #1
Title Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.
Authors M.S.O'Reilly, T.Boehm, Y.Shing, N.Fukai, G.Vasios, W.S.Lane, E.Flynn, J.R.Birkhead, B.R.Olsen, J.Folkman.
Ref. Cell, 1997, 88, 277-285. [DOI no: 10.1016/S0092-8674(00)81848-6]
PubMed id 9008168
Full text Abstract
Figure 2.
Figure 2. Purification of an Inhibitor of Endothelial Proliferation from EOMA-Conditioned Media(A) SDS-PAGE. An aliquot ( vert, similar 100 ng) of the purified inhibitor of endothelial cell proliferation was analyzed by electrophoresis in a 10%–18% polyacrylamide gel. Inhibitory activity was associated with a protein of apparent M[r] 20,000 (silver stain). Molecular mass markers (× 10^−3) are as indicated.(B) Amino acid sequence. The N-terminal sequence of the purified inhibitor of endothelial cell proliferation (endostatin) is noted in relation to a schematic of collagen XVIII. N-termi- nal sequence reveals identity of the inhibitor to a 20 kDa C-terminal fragment (solid shading) of collagen XVIII. We have named this inhibitor endostatin. The open boxes represent the collagenous domains of collagen XVIII.
Figure 7.
Figure 7. Systemic Therapy with Recombinant Endostatin Regresses a Wide Variety of Primary MalignanciesThe subcutaneous dorsa of mice were implanted with Lewis lung carcinomas and systemic therapy with recombinant mouse endostatin (20 mg/kg/day) was begun when tumors were vert, similar 200 mm^3 (1% of body weight). Tumors in the mice treated with endostatin rapidly regressed and were inhibited by >99% relative to saline-treated controls (n = 5). Each point represents mean ± SEM for ten (T241), four (B16F10), or three (EOMA) mice.
The above figures are reproduced from the cited reference with permission from Cell Press
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer